Libre Duo 10 Day Tracks Glucose and Ketones - TechRepublic
Abbott’s Libre Duo 10 Day combines continuous glucose and ketone monitoring in one FDA-authorized wearable sensor. Image: Generated by ChatGPT.
Abbott’s Libre Duo 10 Day continuously tracks glucose and ketones from one sensor, with a US launch planned for later in 2026.
Sep 3, 2026
We may earn from vendors via affiliate links or sponsorships. This might affect product placement on our site, but not the content of our reviews. See our Terms of Use for details.
Abbott’s Libre Duo 10 Day has become the first wearable authorized in the US to continuously monitor ketones and the first device in the world to continuously track both ketones and glucose from a single sensor.
The FDA authorized the system on August 25, 2026, for people ages 2 and older living with diabetes. Abbott plans to launch it in the US later this year, but the company has not announced a specific...
Copyright of this story solely belongs to www.techrepublic.com. To see the full text click HERE
